Form 4 for ONCO Onconetix, Inc.

Accepted 2025-08-19 00:00:00 ET · period of report 2025-08-15 · accession 0001213900-25-078488 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2025-08-19	2025-08-15	ONCO	Tarsh Simon	Dir	A - Grant	$0.00	+618	658	+1,545%	$0
	2025-08-19	2025-08-15	ONCO	Tarsh Simon	Dir	J - Other	$0.00	+39	40	+3,900%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-08-15	A	A	618	$0.00	658	D	—	—	(F3) Represents a restricted stock award granted to the Reporting Person pursuant to the 2022 Plan. The award will vest in full on August 31, 2026 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date.
2	Common	Common Stock	2025-08-15	J	A	39	$0.00	40	D	—	—	(F2) On June 13, 2025, the Issuer effected a 1-for-85 reverse split of its Common Stock. The amounts set forth herein are presented on a post-split basis. (F1) Represents a restricted stock award originally granted to the Reporting Person on September 26, 2024 pursuant to the Issuer's 2022 Equity Incentive Plan, as amended ("2022 Plan" and the grant on such date, the "Original Award"). On August 15, 2025, the Original Award was modified to change the vesting terms, such that the award, which was to vest in full on August 31, 2025, was changed to vest in full on August 31, 2026, so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date. Except as set forth herein, the Original Award remains unmodified.